patrick.net

Residual DNA in RNA vaccines. 3 page Q and A.
From Professors Ulrike Kammerer and Klaus Steer in Germany RNA 疫苗中的残留 DNA。 3页问答。
来自德国 Ulrike Kammerer 和 Klaus Steer 教授
MERYL NASS
JAN 12

https://open.substack.com/pub/merylnass/p/residual-dna-in-rna-vaccines-3-page

READ IN APP

Below is a very brief, clearly stated and well footnoted 3 pages of the basic information needed to understand the impact of the DNA plasmids in the Pfizer vaccines. It can be shared with officials who make decisions about the use of the modified mRNA vaccines, and others who want a short but clear summary of this important subject.

https://www.mwgfd.org/2025/01/residual-dna-in-rna-based-genetic-vaccines-questions-answers/

Since February 2023, various international laboratories have detected residues of plasmid DNA in all tested COVID-19 “vaccine” batches from Pfizer/BioNTech and Moderna at concentrations well above the current limit. In the following brief document, Prof. Ulrike Kämmerer and Prof. Klaus Steger address important questions about genetic vaccines and the origin of residual DNA.

At the end of 2024, a team from MWGFD was able to detect large amounts of residual DNA in RNA-based genetic vaccines from BioNTech, including the SV40 promoter/enhancer sequence, which is absolutely unnecessary for production, but highly dangerous [https://publichealthpolicyjournal.com/biontech-rna-based-covid-19-injections-contain-large-amounts-of-residual-dna-including-an-sv40-promoter-enhancer-sequence/].

In the following article, our two members Prof. Dr. Klaus Steger and Prof. Dr. Ulrike Kämmerer have summarized the current study situation on the detection of residual DNA in RNA-based genetic vaccines from Pfizer/BioNTech and Moderna.

Shortly after this overview was completed, a peer-reviewed study carried out by students in a FDA laboratory was published [https://jhss.scholasticahq.com/article/127890-a-rapid-detection-method-of-replication-competent-plasmid-dna-from-covid-19-mrna-vaccines-for-quality-control], which, in addition to the high DNA concentrations measured, was also able to prove that the plasmid-DNA fragments contained were indeed replication-competent, which had previously always been denied by official authorities. It therefore remains to be seen whether and how the FDA and the EMA will react to these new explosive results. RNA 疫苗中的残留 DNA。 3页问答。
来自德国 Ulrike Kammerer 和 Klaus Steer 教授
梅丽尔·纳斯
1月12日

在应用程序中阅读

下面是 3 页非常简短、表述清楚且脚注清楚的基本信息，旨在了解辉瑞疫苗中 DNA 质粒的影响。 它可以与对改良 mRNA 疫苗的使用做出决定的官员以及希望对这一重要主题进行简短而清晰的总结的其他人共享。
…
自 2023 年 2 月以来，多个国际实验室在辉瑞/BioNTech 和 Moderna 的所有测试的 COVID-19“疫苗”批次中检测到质粒 DNA 残留，其浓度远高于当前限值。 在下面的简短文件中，Ulrike Kämmerer 教授和 Klaus Steger 教授讨论了有关基因疫苗和残留 DNA 起源的重要问题。

2024年底，MWFD的一个团队能够在BioNTech的基于RNA的基因疫苗中检测到大量残留DNA，其中包括SV40启动子/增强子序列，这对于生产来说是绝对不需要的，但非常危险
…

在接下来的文章中，我们的两位成员Klaus Steger教授和Ulrike Kämmerer教授总结了目前辉瑞/BioNTech和Moderna的RNA基因疫苗中残留DNA检测的研究情况。

本概述完成后不久，FDA 实验室的学生进行的一项同行评审研究发表了…🔗📑，除了测量的高 DNA 浓度外，还能够证明 所含的质粒DNA片段确实具有复制能力，此前官方一直否认这一点。 因此，FDA 和 EMA 是否以及如何对这些新的爆炸性结果做出反应还有待观察。